63rd ASH Annual Meeting and Exposition
Restrict search results to: Date Session Type Oral Poster Abstract Category (limits search results to the Abstract Program) Hematology…
Related Articles
Paper: Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access and Barriers to Chemoimmunotherapies and Transplant
Program: Oral and Poster Abstracts Session: 652. Multiple Myeloma: Clinic al and Epidemiological: Poster III Hematology Disease Topics & Pathways: Research, Clinical Practice (Health Services…
The US was getting too expensive. So this artist relocated to France for a slower-paced life | CNN
Swapping the US for the French Pyrenees wasn’t part of Taylor Barnes’ plan. But as the cost of living in the US increased, the Los…
Paper: Phase III Study of Daratumumab/rhuph20 (nsc- 810307) + Lenalidomide or Lenalidomide As Post-Autologous Stem Cell Transplant Maintenance Therapyin Patients with Multiple Myeloma (mm) Using Minimal Residual Disease Todirect Therapy Duration (DRAMMATIC study): SWOG s1803
Program: Oral and Poster Abstracts Session: 731. Clinical Autologous Transplantation: Results: Poster I Hematology Disease Topics & Pathways: Adult, Non-Biological, Therapies, Study Population, Clinically relevant…
Paper: Phase III Study of Daratumumab/rhuph20 (nsc- 810307) + Lenalidomide or Lenalidomide As Post-Autologous Stem Cell Transplant Maintenance Therapyin Patients with Multiple Myeloma (mm) Using Minimal Residual Disease Todirect Therapy Duration (DRAMMATIC study): SWOG s1803
Program: Oral and Poster Abstracts Session: 731. Clinical Autologous Transplantation: Results: Poster I Hematology Disease Topics & Pathways: Adult, Non-Biological, Therapies, Study Population, Clinically relevant…
Starvation as a weapon of war must stop
The theme of World Health Day on April 7 is ‘my health, my right’, underscoring the UN’s assertion that “every human being is entitled to…
Starvation as a weapon of war must stop
The theme of World Health Day on April 7 is ‘my health, my right’, underscoring the UN’s assertion that “every human being is entitled to…
Paper: Phase III Study of Daratumumab/rhuph20 (nsc- 810307) + Lenalidomide or Lenalidomide As Post-Autologous Stem Cell Transplant Maintenance Therapyin Patients with Multiple Myeloma (mm) Using Minimal Residual Disease Todirect Therapy Duration (DRAMMATIC study): SWOG s1803
Program: Oral and Poster Abstracts Session: 731. Clinical Autologous Transplantation: Results: Poster I Hematology Disease Topics & Pathways: Adult, Non-Biological, Therapies, Study Population, Clinically relevant…
Scholars for the Public Good
Signed by more than 200 faculty of diverse ranks, schools and disciplines, our letter urges our university’s new leadership to protect critical thought and expression…
‘Patient Is Otherwise Healthy’
Let me start by saying: I know I am one of the fortunate ones. Being diagnosed with cancer at any age puts many in a…